NIXX Q3 2023 Earnings EPS Surprises to the Upside Amid Revenue Disclosures NXTC Q1 2026 Earnings SmallerthanExpected Loss but Stock Plunges 22 as Revenue Stays at Zero MLYS Q1 2026 Earnings Narrow Beat on Losses as Clinical Pipeline Progress Continues ACET Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path Empery Digital Inc EMPD Q1 2026 Earnings Steep EPS Miss Clouds Growth Narrative as Stock Defies Gravity